Načítá se...
Immunotherapy in Genitourinary Malignancies
PURPOSE OF REVIEW: Active investigation suggests immune checkpoint inhibitor therapy and therapeutic cancer vaccines provide clinical benefit for genitourinary (GU) malignancies including prostate cancer, renal cell carcinoma (RCC) and bladder cancer. Recent developments in the utility of immune che...
Uloženo v:
| Vydáno v: | Curr Opin Urol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5129842/ https://ncbi.nlm.nih.gov/pubmed/27471994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOU.0000000000000331 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|